Shenzhen Hepalink Pharmaceutical Group . Stock Forecast

Sell candidate since Jul 27, 2026 Loss -0.69%

No changes to the price of Shenzhen Hepalink Pharmaceutical Group stock on the last trading day (Friday, 31st Jul 2026). During the last trading day the stock fluctuated 1.42% from a day low at HK$4.24 to a day high of HK$4.30. The price has fallen in 6 of the last 10 days but is still up by 2.14% over the past 2 weeks.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at HK$4.38 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -10.36% during the next 3 months and, with a 90% probability hold a price between HK$3.25 and HK$3.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

9989.HK Signals & Forecast

The Shenzhen Hepalink Pharmaceutical Group stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately HK$4.33. On a fall, the stock will find some support from the long-term average at approximately HK$4.15. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 22, 2026, and so far it has fallen -3.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Shenzhen Hepalink Pharmaceutical Group stock

Shenzhen Hepalink Pharmaceutical Group finds support from accumulated volume at HK$4.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved HK$0.0600 between high and low, or 1.42%. For the last week the stock has had daily average volatility of 1.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (9989.HK) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Shenzhen Hepalink Pharmaceutical Group Co., Ltd. to open at HK$4.28, and during the day (based on 14 day Average True Range), to move between HK$4.24 and HK$4.36, which gives a possible trading interval of +/-HK$0.125 (+/-2.94%) up or down from last closing price. If Shenzhen Hepalink Pharmaceutical Group Co., Ltd. takes out the full calculated possible swing range there will be an estimated 2.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at HK$4.44 (3.26%) than the support at HK$4.14 (3.72%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. stock A Buy?

Shenzhen Hepalink Pharmaceutical Group holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.721 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - HK$4.28 ( 0.465%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk